QUESTION READOUT · 06
KPV peptide: frequently asked questions
Direct answers from the published literature — what the studies measured, and where the human record stops.
What is KPV peptide good for?
In research models KPV is studied mainly as an anti-inflammatory tripeptide, with the largest evidence base in gut and colitis models and additional work in skin, wound healing, and epithelial signaling [1][6]. Oral KPV reduced colitis severity in mice and topical KPV closed corneal wounds in rabbits [1][6]. It is research-only with no validated human use [1].
Does KPV cause skin pigmentation or tanning like other melanocortins?
No. KPV is the C-terminal alpha-MSH fragment that retains anti-inflammatory activity while lacking the parent hormone's pigmentary (melanogenic) action [4]. That loss of tanning effect is its defining feature in the literature and the reason it is studied apart from melanocortin agonists used in pigmentation research [4].
What is KPV cream used for?
Topical and biomaterial-delivered KPV has been studied in skin and wound-repair models — keratinocyte signaling, environmental skin stress, and mucoadhesive dressings [7][9][13]. These are research formulations, not approved cosmetic or medical creams [9]. No human cosmetic or therapeutic KPV cream is established [9].
Has KPV been studied for wound healing?
Yes. Topical alpha-MSH(11-13)/KPV accelerated corneal epithelial wound healing in rabbits — 8 of 8 corneas re-epithelialized by 60 hours versus none on placebo [6]. KPV also appears in cutaneous wound-repair and tripeptide regeneration reviews as a pro-repair candidate [8][13]. These are animal and review findings, not human outcomes [6].
Can KPV help skin exposed to pollution or fine dust?
A 2025 in vitro study found the Lysine-Proline-Valine peptide reduced fine-dust (particulate-matter)-induced keratinocyte apoptosis and inflammation, suggesting a protective role against environmental skin stress in cell models [9]. This is a cell-culture finding and has not been tested in human skin [9].
What is KPV peptide?
KPV is the linear tripeptide lysine-proline-valine (Lys-Pro-Val), corresponding to residues 11-13 (the C-terminal sequence) of alpha-melanocyte-stimulating hormone, studied as a melanocortin-derived anti-inflammatory peptide [4]. It is a fragment of the larger hormone, not an independently circulating hormone [4].
What does KPV peptide do?
In research models KPV dampens inflammation, primarily by suppressing NF-kB and MAP-kinase signaling and reducing pro-inflammatory cytokine production [1]. In the gut it is taken up directly into epithelial cells via the PepT1 transporter, which is upregulated in inflamed tissue [1].
What is KPV peptide used for?
Research uses cluster around intestinal inflammation and colitis (its largest literature), anti-inflammatory and immune signaling, wound healing, skin, and antimicrobial activity [1][4]. There is no approved human indication [9].
Is KPV peptide safe?
Human safety is unestablished: there are no published human clinical trials of KPV and no validated human pharmacokinetics [1]. The evidence base is in vitro and animal, and KPV is research-use-only [1][9]. Preclinical work measured efficacy and mechanism, not human safety [1].
What are the benefits of KPV peptide?
Reported preclinical benefits include reduced colonic inflammation, anti-inflammatory signaling across cell types, accelerated corneal and cutaneous wound healing, barrier protection, and antimicrobial activity [1][4][6]. All are research findings in cells and animals, not clinical outcomes [1].
Who should not take KPV peptide?
KPV is not approved for human use and has no clinical safety data, so the literature does not define eligible or ineligible human populations [1]. It is intended only for laboratory research, and the published work does not address human use at all [1][9].
How long does it take KPV peptide to work?
No human timeline exists [1]. In animal colitis models effects emerged over days of dosing, and in the rabbit cornea full re-epithelialization occurred by ~60 hours — but these are species- and model-specific research observations, not human timelines [1][6].
Can you take KPV every day?
There is no validated human dosing schedule [1]. Animal studies used continuous oral delivery (for example, ~100 uM in drinking water) or repeated daily topical dosing; none of this translates to a human regimen [1][6].
Is KPV peptide worth it?
From a research standpoint KPV is a mechanistically interesting anti-inflammatory tripeptide with reproducible preclinical effects [1][2]. Its evidence is preclinical only, so any "worth" judgment for human use is unsupported by clinical data [1].
Can you take KPV and BPC-157 together?
The KPV literature does not include controlled human combination studies with BPC-157 [1]. Any combined use is outside the published research, which evaluates KPV on its own in cells and animals [1]. No combination data exist to summarize [1].
How often do I inject KPV peptide?
Research administration of KPV has been oral (drinking water, nanoparticle, or hydrogel) and topical, not injection [1][5][6]. There is no established injection frequency for human use, and the gut work specifically develops oral, PepT1-targeted delivery [1][5].
How quickly does KPV peptide work?
Onset is model-dependent in preclinical work — hours in the rabbit cornea, days in mouse colitis — and undefined in humans, where no pharmacokinetic or efficacy timeline has been published [1][6].
How long should I take KPV peptide for?
No human duration is established [1]. Animal protocols ran for the length of the disease model — for example, a multi-day colitis course — which are experimental designs, not human dosing guidance [1][6].
What is KPV peptide dosage?
Research doses span ~10 nM in vitro up to low-micromolar in cells, ~100 uM oral in mouse colitis, and 1-10 mg/mL topical eye drops in rabbits [1][6]. No established or validated human research dose exists [1].
What are KPV peptide side effects?
Because there are no human trials, a human side-effect profile has not been characterized [1]. Preclinical reports emphasize anti-inflammatory activity rather than documented toxicity, but this is not a safety clearance for humans [1].
What is KPV?
KPV is shorthand for the tripeptide lysine-proline-valine, the C-terminal fragment (residues 11-13) of alpha-MSH, studied as an anti-inflammatory research peptide that lacks the parent hormone's pigmentary effect [4].
What is KPV used for?
In the research literature KPV is used to study anti-inflammatory signaling, intestinal and colitis inflammation via PepT1 uptake, wound healing, skin protection, and epithelial barrier function [1][6]. It has no approved human use [9].
How KPV differs from BPC-157 in the literature
KPV and BPC-157 are studied as distinct peptides with different origins and mechanisms. KPV is the C-terminal tripeptide of alpha-MSH and acts chiefly as an anti-inflammatory signal via NF-kB/MAPK suppression and PepT1 uptake, with its deepest literature in gut colitis models [1][4]. The KPV literature does not contain controlled head-to-head or combination studies with BPC-157, so any comparison is structural and mechanistic, not a measured clinical contrast [1].
Is KPV legal?
KPV is sold by chemical suppliers for laboratory research use only and is not an approved drug or dietary supplement in any major jurisdiction [17]. It is not FDA-approved, and it is scheduled for FDA PCAC evaluation rather than listed for compounding [16][17].
Can you get KPV from a compounding pharmacy?
KPV has no approved drug status, and a 503A pharmacy may compound with a bulk substance only when it has a USP/NF monograph, is part of an approved drug, or is on the FDA bulks list [16]. KPV meets none of these today and is under FDA evaluation, so access is research-only [16][17].
What is the FDA 503A status of KPV?
KPV is not FDA-approved and has no recognized USP/NF monograph; it is scheduled for PCAC evaluation for possible inclusion on the 503A bulks list at the July 23-24, 2026 meeting, which is a discussion, not a listing [16][17]. No numbered 503A category is assigned to KPV here, consistent with the audited FDA reference [16].